Send me a link:

*Text messaging rates may apply.

 Dow Down0.02% Nasdaq Down0.04%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM
1.58 Up 0.01(0.64%) Jul 24, 4:00PM EDT
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Jul 14
Next Qtr.
Oct 14
Current Year
Apr 15
Next Year
Apr 16
Avg. Estimate-0.06-0.07-0.27-0.32
No. of Analysts3.003.003.002.00
Low Estimate-0.06-0.07-0.28-0.35
High Estimate-0.06-0.06-0.26-0.29
Year Ago EPS-0.05-0.05-0.22-0.27
Revenue EstCurrent Qtr.
Jul 14
Next Qtr.
Oct 14
Current Year
Apr 15
Next Year
Apr 16
Avg. Estimate6.03M6.13M25.36M22.05M
No. of Analysts2222
Low Estimate4.99M5.19M22.40M19.90M
High Estimate7.08M7.08M28.31M24.20M
Year Ago Sales4.69M7.35M22.40M25.36M
Sales Growth (year/est)28.60%-16.60%13.20%-13.10%
Earnings HistoryJul 13Oct 13Jan 14Apr 14
EPS Est-0.05-0.05-0.06-0.07
EPS Actual-0.05-0.05-0.06-0.06
Difference0.000.000.000.01
Surprise %0.00%0.00%0.00%14.30%
EPS TrendsCurrent Qtr.
Jul 14
Next Qtr.
Oct 14
Current Year
Apr 15
Next Year
Apr 16
Current Estimate-0.06-0.07-0.27-0.32
7 Days Ago-0.06-0.07-0.27-0.32
30 Days Ago-0.06-0.06-0.24-0.31
60 Days Ago-0.06-0.06-0.24-0.31
90 Days Ago-0.06-0.06-0.24-0.31
EPS RevisionsCurrent Qtr.
Jul 14
Next Qtr.
Oct 14
Current Year
Apr 15
Next Year
Apr 16
Up Last 7 Days0000
Up Last 30 Days0000
Down Last 30 Days0021
Down Last 90 DaysN/AN/AN/AN/A
Growth EstPPHMIndustrySectorS&P 500
Current Qtr.-20.00%N/A-64.70%14.40%
Next Qtr.-40.00%N/A-62.60%17.30%
This Year-22.70%N/A100.70%8.00%
Next Year-18.50%N/A45.40%12.30%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A21.57%15.38%9.78%
Price/Earnings (avg. for comparison categories)-5.817.506.7019.06
PEG Ratio (avg. for comparison categories)N/A26.787.182.49
Currency in USD.